InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

PALISADE BIO, INC.

PALI Clue Score57
United States Fiscal year ends December CIK 0001357459 Results filed 10 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

40
Insider
Date
Role
Action
Shares
Price
Amount
Donald Allen Williams
2 Oct 2026
Director
Buy
10,000
$1.46
$14.60K
Donald Allen Williams
1 Oct 2026
Director
Buy
10,000
$1.42
$14.20K
Robert Baltera Jr.
9 Jul 2026
Director
Buy
25,000
$1.96
$48.90K
Robert Baltera Jr.
8 Jul 2026
Director
Buy
20,000
$1.99
$39.80K
Robert Baltera Jr.
7 Jul 2026
Director
Buy
30,000
$2.03
$61.04K
Robert Baltera Jr.
6 Jul 2026
Director
Buy
20,000
$2.05
$41.04K
Robert Baltera Jr.
2 Jul 2026
Director
Buy
10,000
$1.98
$19.80K
Robert Baltera Jr.
1 Jul 2026
Director
Buy
20,000
$1.98
$39.60K
Donald Allen Williams
16 Jan 2026
Director
Buy
5,000
$1.67
$8.36K
Donald Allen Williams
9 Jan 2026
Director
Buy
5,000
$1.88
$9.40K
Donald Allen Williams
28 May 2024
Director
Buy
1,000
$4.86
$4.86K
John David Finley
24 May 2024
CEO, CFO, Director
Buy
1,000
$4.81
$4.81K
John David Finley
6 Feb 2024
CEO, CFO, Director
Buy
10,000
$0.47
$4.69K
Donald Allen Williams
31 Jan 2024
Director
Buy indirect
10,000
$0.61
$6.05K
John David Finley
31 Jan 2024
CEO, CFO, Director
Buy
10,000
$0.56
$5.59K
John David Finley
27 Sep 2023
CEO, CFO, Director
Buy
15,000
$0.54
$8.09K
Donald Allen Williams
27 Sep 2023
Director
Buy indirect
20,000
$0.54
$10.80K
John David Finley
13 Sep 2023
CEO, CFO, Director
Buy
15,000
$0.66
$9.83K
John David Finley
1 Sep 2022
Chief Financial Officer
Buy
19,481
$0.14
$2.80K
John David Finley
23 Aug 2022
Chief Financial Officer
Buy
7,350
$0.16
$1.18K
John David Finley
16 Aug 2022
Chief Financial Officer
Buy
100,000
$0.25
$25.00K
Thomas Hallam
16 Aug 2022
Chief Executive Officer
Buy
40,000
$0.25
$10.00K
Michael John Dawson
29 Mar 2022
Chief Medical Officer
Buy
15,000
$1.14
$17.09K
Thomas Hallam
28 Mar 2022
Chief Executive Officer
Buy
10,000
$1.18
$11.80K
John David Finley
24 Mar 2022
Chief Financial Officer
Buy
7,500
$1.09
$8.17K
Thomas Hallam
21 Sep 2021
Chief Executive Officer
Buy
6,000
$2.49
$14.94K
John David Finley
21 Sep 2021
Chief Financial Officer
Buy
2,000
$2.44
$4.88K
Robert J. Trenschel
10 Sep 2021
Director
Buy
2,142
$2.98
$6.38K
Robert J. Trenschel
9 Sep 2021
Director
Buy
3,400
$2.89
$9.83K
Robert J. Trenschel
8 Sep 2021
Director
Buy
5,000
$2.75
$13.75K
Robert J. Trenschel
7 Sep 2021
Director
Buy
2,707
$2.78
$7.53K
Robert J. Trenschel
31 Aug 2021
Director
Buy
1,750
$2.75
$4.81K
John David Finley
27 Aug 2021
Chief Financial Officer
Buy
8,400
$2.65
$22.26K
John David Finley
27 Aug 2021
Chief Financial Officer
Buy
1,600
$2.63
$4.21K
Richard J Daly
17 May 2017
Chief Executive Officer
Buy
7,500
$4.00
$30.00K
Jones Jonathan Brian Lloyd
24 Mar 2017
Chief Financial Officer
Buy
5,455
$5.50
$30.00K
Richard J Daly
24 Feb 2017
Chief Executive Officer
Buy
2,591
$3.86
$10.00K
Richard J Daly
25 Jan 2017
Chief Executive Officer
Buy
2,841
$3.52
$10.00K
Richard J Daly
23 Dec 2016
Chief Executive Officer
Buy
32,259
$0.31
$10.00K
Richard J Daly
25 Nov 2016
Chief Executive Officer
Buy
35,715
$0.28
$10.00K
Show all 45 transactions →

What was left out

Form 4 filings counted 154
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 1
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 13,933,636
History held since 19 Mar 2007